Basic Information
ID: ALA4626535
Type: ADME
Description: Drug metabolism in human NCI-H2122 cells assessed as (R)-4-(amino(phenyl)methyl)-N-(6-hydroxybenzo[d]thiazol-2-yl)-benzamide formation at 100 nM by in presence of CYP4F inhibitor HET0016 LC-MS/MS analysis
Organism: Homo sapiens
Cell type: NCI-H2122
Activity Charts
Bioactivity
Activity Types for Assay ALA4626535
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 389.48 | 4.61 | 4.61 |